Viridian Therapeutics Earnings
NASDAQ: VRDNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.08
Viridian Therapeutics earnings summary
Viridian Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-1.08. In its most recent report on Nov 12, 2024 (Q3 2024), VRDN posted EPS of $-1.15. Revenue for the quarter was $86,000.
Across the last 13 reports, VRDN shares moved an average of 1.8% (in either direction) in the first trading session after results, rising 7 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
VRDN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 12, 2024 | — | $-1.15 | — | +0.3% |
| Aug 8, 2024 | — | $-1.02 | — | +3.1% |
| May 8, 2024 | — | $-0.79 | — | -3.2% |
| Feb 27, 2024 | — | $-1.34 | — | -3.8% |
| Nov 13, 2023 | — | $-1.09 | — | +2.7% |
| Aug 8, 2023 | — | $-1.27 | — | -0.9% |
| May 10, 2023 | — | $-1.61 | — | -1.5% |
| Mar 9, 2023 | — | $-1.15 | — | -3.4% |
| Nov 14, 2022 | — | $-0.86 | — | +1.2% |
| Aug 15, 2022 | — | $-1.06 | — | +2.0% |
| May 13, 2022 | — | $-0.98 | — | +0.4% |
| Mar 11, 2022 | — | $-0.29 | — | -0.4% |
| Nov 5, 2021 | — | $-1.25 | — | +1.1% |
| Aug 12, 2021 | — | $-2.21 | — | — |
| May 7, 2021 | — | $-2.91 | — | — |
| Mar 26, 2021 | — | $-28.26 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.